Finding a company involved in the cloud that's valued at less than 10 times sales is practically impossible. The coronavirus pandemic demonstrated how important online and cloud access are for businesses, which coerced investors to pay insane multiples. The thing about Cloudera is that it wasn't always a cloud company. Over roughly the past year, it's moved away from its legacy data platform and has pushed its new hybrid Private Cloud and Public Cloud offerings.
This ongoing transformation allows the company to generate cash flow from its legacy operations, while also transitioning these enterprise customers into higher-margin, cloud-native platforms.
If fully completed, Cloudera could retire an eighth of its outstanding shares. Buyback programs tend to lift earnings per share and make a company appear more fundamentally attractive to investors. With sales growth likely to exceed Wall Street's expectations in calendar year , and the company valued at just over 4 times forward-year sales, Cloudera has plenty of reason to rocket higher this year. Though Canadian marijuana stocks have been an awful investment up this point, OrganiGram has a couple of unique advantages that could allow it to surprise Wall Street in a big way in One of the biggest issues with Canadian pot stocks is that they've been hamstrung by regulators at the federal and provincial level.
The good news is that key provinces, like Ontario , have begun opening new dispensaries at a steady rate. In other words, the supply bottlenecks that've crushed margins and consumer demand should become a thing of the past this year. Instead of opening multiple grow sites, acquiring other businesses, and overextending capacity, OrganiGram has been exclusively focused on Moncton. Having just one site allows it to be more nimble with regard to cost-cutting, production, and product mix.
To build on this point, OrganiGram also employs three tiers in its cultivation rooms, which maximizes its licensed space and helps to improve overall yield. It wouldn't surprise me if OrganiGram's cost-cutting, coupled with the maturation of the Canadian pot industry, allowed the company to eke out a profit in With its shares so deeply depressed, it wouldn't take much for this stock to double.
The beauty of the EverQuote model is that it's built to take advantage of insurers switching their customer capture activity online. Though the company has historically generated most of its revenue from auto insurance, it's been shifting into new verticals organically and through acquisitions e.
This includes health, home, renters, and life insurance. These newer verticals have been growing at a much faster pace than its traditional insurance segment, and they've been responsible for EverQuote regularly upping its full-year sales forecast. The simple fact is that EverQuote's platform is a win-win for both parties. It's a simple platform for consumers to quickly price-shop for insurance without filling out a mountain of forms, and it's an efficient way for insurers to land motivated consumers.
EverQuote offers sustainable double-digit growth, yet is valued at less than 3 times forward-year sales. That's a bargain I suspect won't stay a bargain for much longer. To keep things short and sweet, Teva's been clobbered in recent years by a bribery settlement, its association with the opioid crisis, and due to allegations of generic-drug price-fixing.
Schultz's tenure began in November Aside from improved financial flexibility, Schultz should also be responsible for navigating Teva out of its legal mess. If the company can resolve its outstanding opioid and price-fixing lawsuits without much in the way of cash penalties, that alone could more than double Teva's share price. At less than 4 times forward earnings , I'll be looking for a serious rebound in In case you haven't noticed, U.
What's unique about Jushi is the company's focus on the limited license states of Pennsylvania, Virginia, and Illinois. Investors don't seem to care too much, evidently; as of a. EST today, shares are up The Swedish maker of health-conscious energy drinks is sliding down from last week's all-time highs.
A mixed earnings report didn't exactly help. After the recent pullback, the big data specialist's stock is now down roughly 3. There was no company-specific news or developments, so why did the fuel-cell stock gain so much in value?
PayPal specializes in digital payments. Our overall message is optimistic,". Lucid Motors earnings are due Monday, with the Tesla rival's production goals in focus. Shares have soared on Lucid Air EV deliveries. EST Friday after the big drugmaker announced its third-quarter results. This week was a rather volatile one for the investors in cryptocurrency miners. The recent spin-off of its managed infrastructure business into a company called Kyndryl NYSE: KD removes a noncore business from its balance sheet.
Also, management promised that the two companies would maintain the current combined dividend. The metaverse has just begun, and Nvidia CEO Jensen Huang says it will be "much, much bigger" than the physical world. Remember Inovio INO , the small biotech punching above its weight and mingling with pharma giants in the early attempts to stamp out the Covid pandemic? Dow 30 36, Nasdaq 15, Russell 2, Crude Oil Gold 1, Silver The stock is still a Dow component to this day.
The original Hewlett-Packard, started in , was the granddaddy of Silicon Valley technology firms. The stock was added to the Dow in Two years later the company spun off Agilent Technologies A to house products that didn't relate to computers, such as scientific instruments and semiconductors. The beginning of the end for the original Hewlett-Packard started with the ill-fated acquisition of Compaq to form the world's largest maker of PCs.
Soon after, the PC market became saturated. Attempts to restart growth with smartphones and tablets were unsuccessful, losses mounted, and management was forced to lay off tens of thousands of employees. HP Inc. But as the card gained popularity abroad, the name was changed in to Visa because it was easier to pronounce.
Today, Visa is the world's largest payments processor outside of China. Interestingly, shares in the company held up relatively well during the crash of and bounced back sharply as the market started to recover. Cisco Systems, founded in and a publicly traded company since , was one of the premier tech stocks of the dot-com boom. It suffered along with much of the technology sector when the bubble burst in , but it was no Pets.
Demand for the routers, switches and modems manufactured by Cisco that form the backbone of the Internet helped the company recover quickly. In , Cisco was added to the Dow as stocks were finally emerging from the brutal bear market precipitated by the housing crisis and the global financial meltdown. That said, Cisco shares have been something of a disappointment since the current bull market began. Today, the company is reconfiguring itself to take advantage of the growth of cloud-based computing and the Internet of Things.
Schlumberger is the world's largest oil-field services company. As such, it helps firms that own rights to oil fields to actually find the oil and drill the wells, among other services. The company was founded in by two brothers from France, and a steady stream of technological innovations and acquisitions have contributed to its rapid growth over the decades.
Schlumberger's history largely parallels the spread of the combustion engine and the rise of oil as the king commodity, which helps explain its elite level of wealth creation for shareholders. Don't be surprised if this long-time wealth creator bounces back sooner rather than later.
Ticker symbol: AMGN. The biotech industry has long held allure for investors looking for outsized returns, and Amgen is part of the reason why. The world's largest biopharmaceutical company has created an eye-popping level of wealth for shareholders in its relatively short life.
It was founded in and went public three years later. Amgen has delivered such returns by following the pharmaceutical industry playbook of both developing hit drugs on its own and acquiring other companies and their blockbusters. Current best-sellers include Neulasta, which helps prevent infections in chemotherapy patients, and Enbrel, which is primarily used to treat autoimmune diseases such as rheumatoid arthritis. Boeing, a Dow component since , forms half of the duopoly for large commercial airliners.
Only Europe's Airbus competes with it on the same level in making big jets. But Boeing is much more than just commercial aviation. The company is a major defense contractor, manufacturing everything from rockets to satellites to military tilt-rotor aircraft like the Osprey. Boeing's history reaches back a century, but it really came into its own in the post-World War II period with the explosive growth of commercial aviation.
Warner-Lambert was acquired by Pfizer PFE some 17 years ago, but during its half century as an independent publicly traded company, its stock delivered a remarkable performance. Tracing its roots back to the mids, Warner-Lambert was no stranger to making plenty of big acquisitions of its own over the years. Management initially partnered with Pfizer to market the cholesterol-lowering drug, but Lipitor proved so popular that Pfizer acquired Warner-Lambert outright in It proved to be a good decision.
Lipitor went on to become the best-selling prescription drug of all time. The world's largest independent oil exploration and production company was formed by the merger of Conoco and Phillips Petroleum, both of which had long and successful records in the petroleum industry. Conoco, once owned by DuPont, was founded in , and the Phillips story begins in ConocoPhillips spun off its transportation and refining business in as Phillips 66 PSX to focus solely on exploration, development and production.
That's what differentiates it today from major integrated energy companies such as ExxonMobil XOM , which also transport and refine oil and natural gas. ConocoPhillips is just one of a number of energy companies that lays claim to greatness when it comes to the lifetime wealth creation of its shares.
As one of the nation's largest cable TV companies and Internet service providers, Comcast has taken more than its fair share of lumps. After all, everyone hates the cable company, right? Everyone, perhaps, except shareholders. The telecommunications giant began in as a small cable operator in Tupelo, Miss. The company originally went public in Add another pharmaceutical maker to the list of the greatest creators of stock market wealth for investors over the year span. The modern-day Bristol-Myers Squibb resulted from the merger of Bristol-Myers and Squibb, but even before joining forces the two separate companies boasted distinguished business lineages that stretch back into the 19th century.
A long track record of successful acquisitions has kept the pipeline primed with big-name drugs over the years. Among the better-known names today are Coumadin, a blood thinner, and Glucophage, for Type 2 diabetes.
Texaco, originally known as The Texas Co. It was first added to the Dow in , when the average expanded to 20 companies from In , its name officially changed to Texaco. The company remained a Dow component until It was an anticlimactic end for one of the last independent oil companies. Texaco was founded in and quickly expanded overseas. By the late s it was the most popular brand of gasoline and one of the earliest sponsors of the nascent television industry.
Such was its success that it managed to become a top wealth creator despite ending its run as a standalone company 16 years ago.
The company was initially known as Bell Atlantic. Today, Verizon is the largest wireless provider in the U. Telecom stocks are known more for income than growth, and Verizon has largely stuck to that script. Amoco boasts a prestigious pedigree, tracing its roots back to John D. Rockefeller's Standard Oil empire of the late 19th and early 20th centuries. In its early days, the company was known as Standard Oil of Indiana.
The name eventually changed to Amoco after regulators broke up Rockefeller's Standard Oil Trust in Amoco opened its first service station in and later moved into oil and gas exploration.
When U. Interestingly, BP in late announced plans to reintroduce Amoco service stations in the U. A string of acquisitions has helped make UnitedHealth Group one of the largest health insurance companies in the world. The company was incorporated under the UnitedHealthcare name in and went public in Since then, it hasn't looked back.
Along the way it beefed up its businesses by buying or merging with MetraHealth, HealthWise of America and AmeriChoice, among many others. The company's OptumRx subsidiary is one of the largest pharmacy benefits managers in the U.
It has also been a very good stock for long-term investors. McDonald's needs no introduction. That's partly because management has a knack for changing with the times. Shares performed poorly in the early s, for example, around the time the low-carb Atkins diet surged in popularity.
McDonald's responded by adding more healthy fare to its menu and the stock recovered. To this day, McDonald's continues to focus on healthier items to compete with new chains boasting fresher offerings, but it was the launch of all-day breakfast in that has given the Golden Arches its latest jolt of life. Its dividend dates back to and has gone up every year since. It should come as no surprise that many of the top-performing stocks since are components of the Dow, which dates back to The popular benchmark is made up of 30 of the bluest blue-chip stocks available to investors, and components change infrequently.
Pfizer, founded in and public since , had to wait until before it was finally added to the industrial average. The pharmaceutical giant earned the honor in large part thanks to its history of selling blockbuster drugs. Among the best known are Lipitor for cholesterol and Viagra for erectile dysfunction. Pfizer also owes its growth to its many successful acquisitions.
Since , it has purchased Warner-Lambert, Pharmacia and Wyeth. Joining the likes of Pfizer and Bristol-Myers Squibb on this list of top-performing stocks is fellow drug maker Abbott Labs. The company has a long and eventful history that dates to its founding in Abbott first paid a dividend in , and it has raised its payout annual for the last 46 years in a row.
The company went public in Its many decades as a dividend-paying public company have certainly attributed to the extraordinary lifetime returns of its stock. Abbott now focuses on generic drugs, medical devices, nutrition and diagnostic products. Technical glitches marred the initial public offering, and the stock traded below the IPO price for more than a year.
Since then, however, it's been nothing but blue skies. The relentless growth of digital advertising bodes well for further gains. Just how explosive has Facebook's rise been? Consider this: In just four and a half years it has created the same amount of wealth for shareholders that it took Abbott Labs nearly 80 years to create.
Disney began as a cartoon studio in , and Mickey Mouse appeared in his first starring role five years later. The company issued stock for the first time in In the decades since, Walt Disney expanded into live-action films, theme parks, toys and television. The stock has nearly tripled in value over the last 10 years, but shares face increasing pressure as viewers cut the cable cord and turn to other forms of entertainment.
But Disney, a Dow component since , has adapted to a changing media landscape before and recently inked a deal to acquire much of 21st Century Fox FOXA. The company began in as a small-time outfit in search of the mineral corundum. Today, 3M makes 60, products, with one-third of sales coming from products invented in the last five years. Shareholders have happily gone along for the ride.
0コメント